Timing of chemotherapy-induced neutropenia predicts prognosis in metastatic colon cancer patients: a retrospective study in mFOLFOX6 -treated patients
Abstract Background The occurrence of Chemotherapy-induced neutropenia (CIN) was reported to be a predictor of better survival in several cancers. The objective of our study is to evaluate the relationship between the timing of CIN and prognosis. Methods Between June 2012 and August 2014, 290 patien...
Main Authors: | Yang Chen, YanRong Wang, Yan Shi, GuangHai Dai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-017-3240-6 |
Similar Items
-
Chemotherapy of metastatic colon cancer
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01) -
Early onset neutropenia: a useful predictor of chemosensitivity and favorable prognosis in patients with serous ovarian cancer
by: Yijing He, et al.
Published: (2020-02-01) -
Current management of chemotherapy-induced neutropenia in adults: key points and new challenges
by: Yi Ba, et al.
Published: (2020-11-01) -
Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study
by: Bernardo Leon Rapoport, et al.
Published: (2018-09-01) -
Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer
by: Feng Wang, et al.
Published: (2019-05-01)